Download Files:
Products Details
Product Description
– AKT-IN-17 is a AKt inhibitor. AKT-IN-17 inhibits AKt in A549 cells, leading to Apoptosis. AKT-IN-17 is a potential anti-NSCLC agents, can be used in non-small cell lung cancer study[1].
Web ID
– HY-149841
Shipping
– Room temperature
Molecular Formula
– C21H21ClN4O2S
References
– [1]Erdönmez B, et al. Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS Omega. 2023 May 24;8(22):20056-20065.
Molecular Weight
– 428.94
SMILES
– O=C(N/N=C/C1=CC=C(N2CCCCC2)C=C1)CSC3=NC4=CC(Cl)=CC=C4O3
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Akt
Pathway
– PI3K/Akt/mTOR
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
